Advanced Filters
noise
Found 61,726 clinical trials

Accelerated Resolution Therapy for Early Maladaptive Grief

The purpose study is to test the effects of accelerated resolution therapy (ART) on pre-loss grief and prolonged grief disorder among older adult family caregivers (FCGs). Additionally, to better understand predictors of response to ART, and cognitive processes that occur among grieving individuals following ART.

60 years of age All Phase N/A

Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel

Background People with rare cancers often have limited treatment options. The biology of rare cancers is not well understood. Researchers want to find better treatments for these cancers. They want to test 2 drugs that, taken separately, have helped people with non-rare cancers. They want to see if these drugs …

18 - 120 years of age All Phase 2
F Franchesca Inay, BS

Impact of Heart Rate Variability Modulation on Stress Management Among Physicians

The purpose of this research is to examine a wearable device called Apollo that emits gentle vibrations found to benefit mood, energy, and focus. We want to understand how it affects burnout in physicians.

18 years of age All Phase N/A
F Fadi Jnaid

Treatment of Skeletal Class II Malocclusion With Modified Twin-Block Appliance With Clear Plates

Patients with skeletal class II malocclusion who have a retracted lower jaw will be treated in this study. The efficacy of clear Plates in the treatment of Skeletal Class II Malocclusion will be assessed. The skeletal, dental and soft tissues changes resulted by this intervention will be studied and compared …

10 - 13 years of age All Phase N/A
A Andy Bolender

Mapping Auricular Vagus Nerve Circuitry

This study will determine how noninvasive nerve stimulation affects human brain, stomach, and autonomic activity.

18 - 65 years of age All Phase N/A
K Karim Mohamed-Noriega, M.D.

Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction

Dry eye syndrome is a common eye disease that affects 1 to 2 out of 10 persons around the planet. One common cause of this disease is the meibomian gland dysfunction. Meibomian glands are very small glands located at the rim of the eyelids that produce an oily substance that …

18 years of age All Phase N/A
L Lyudmila Korostovtseva

The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)

There is a lack of complex studies which could establish the association between genetic circadian factors with the features and short-term outcomes of ischemic stroke, as well as the effects of various auxiliary therapies for circadian rhythm modulation for neuroplasticity enhancement and improvement of short-term outcomes in ischemic stroke. The …

18 - 80 years of age All Phase 4
S Site Public Contact

Venetoclax to Augment Epigenetic Modification and Chemotherapy

The investigator is testing the addition of venetoclax to 5-azacitidine and vorinostat followed by standard chemotherapy to enhance treatment response in AML patients.

1 - 25 years of age All Phase 1

BUBOLight®, a New Phototherapy Device for the Treatment of the Newborn's Jaundice

About 50% of full-term newborns and 80% of premature infants develop jaundice which is due to hyperbilirubinemia. In the majority of cases, jaundice disappears naturally without treatment within three weeks of birth, but the bilirubin level may remain too high, which can lead to a serious neurological disease: kernicterus. To …

- 30 years of age All Phase N/A
Y Yongkun Sun

Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients

In mCRC, response to second-line chemotherapy is limited, and few treatment options are available. It is urgent to design an optimal second-line treatment regimen to improve the response rate and prolong the survival of patients with mCRC. Several studies preliminarily demonstrated that irinotecan, TAS-102 plus bevacizumab regimen could bring promising …

18 - 70 years of age All Phase 1/2

Simplify language using AI